CG
AVXL icon

Cutler Group’s Anavex Life Sciences AVXL Stock Holding History

Cutler Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,300
Closed -$3K – 3777
2022
Q4 		$3K Buy
+5,300
New +$56.6K ﹤0.01% 3423
2022
Q3 		– Sell
-500
Closed -$1K – 4897
2022
Q2 		$1K Sell
500
-3,100
-86% -$29.4K ﹤0.01% 4498
2022
Q1 		$2K Buy
+3,600
New +$44.3K ﹤0.01% 4614
2018
Q1 		– Sell
-16,800
Closed -$7K – 4425
2017
Q4 		$7K Sell
16,800
-27,500
-62% -$108K ﹤0.01% 3362
2017
Q3 		$41K Sell
44,300
-22,000
-33% -$97.8K ﹤0.01% 2419
2017
Q2 		$35K Buy
66,300
+3,500
+6% +$20.2K ﹤0.01% 2835
2017
Q1 		$36K Buy
62,800
+31,200
+99% +$161K ﹤0.01% 2714
2016
Q4 		$42K Buy
31,600
+7,600
+32% +$27.1K ﹤0.01% 2714
2016
Q3 		$48K Buy
24,000
+19,900
+485% +$83.8K ﹤0.01% 2504
2016
Q2 		$1K Sell
4,100
-9,400
-70% -$45.4K ﹤0.01% 5965
2016
Q1 		$16K Buy
13,500
+200
+2% +$880 ﹤0.01% 3516
2015
Q4 		$23K Buy
+13,300
New +$94.6K ﹤0.01% 3254

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Cutler Group's AVXL Position: Q1 2023 in Review

Cutler Group sold out of Anavex Life Sciences (AVXL) in Q1 2023, closing a stake of 1,500 shares — an estimated $13K sold.

Cutler Group first reported a position in AVXL in Q4 2015 and held it in 17 quarters. The position peaked at $72K in Q3 2017. 141 funds tracked by Wall St. Rank hold AVXL as of Q1 2023.

  • Cutler Group reported no remaining Anavex Life Sciences position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 1,500 Anavex Life Sciences shares in Q1 2023, an estimated $13K.
  • Cutler Group first reported a position in Anavex Life Sciences in Q4 2015 and held it in 17 quarters.
  • Cutler Group's Anavex Life Sciences position peaked at $72K in Q3 2017.
  • 141 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.